Axel Mark
3624
Renascience
4889
Ecomott
3987
Festaria Holdings
2736
Tecnisco
2962
(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 12.07%3.98B | 5.25%1.09B | 13.85%1.06B | 6.47%893.11M | 25.67%937.11M | 7.28%3.56B | 5.86%1.04B | 4.62%931.27M | 11.76%838.85M | 7.87%745.71M |
Cost of revenue | 6.74%3.05B | 5.06%834.82M | 9.78%821.99M | 2.95%698.67M | 9.31%690.59M | 5.58%2.85B | 5.12%794.58M | 5.23%748.79M | 8.43%678.66M | 3.64%631.76M |
Gross profit | 33.76%938.61M | 5.84%259.39M | 30.57%238.26M | 21.39%194.44M | 116.34%246.52M | 14.80%701.69M | 8.32%245.08M | 2.19%182.48M | 28.50%160.18M | 39.43%113.95M |
Operating expense | 9.31%672.09M | 10.17%177.15M | 12.08%176.33M | 2.48%152.45M | 12.30%166.16M | 10.94%614.84M | 13.62%160.8M | 10.31%157.33M | 11.42%148.76M | 8.34%147.96M |
Staff costs | 9.84%469.87M | ---- | ---- | ---- | ---- | 10.25%427.77M | ---- | ---- | ---- | ---- |
Selling and administrative expenses | 18.21%34.15M | ---- | ---- | ---- | ---- | 18.98%28.89M | ---- | ---- | ---- | ---- |
-General and administrative expense | 18.21%34.15M | ---- | ---- | ---- | ---- | 18.98%28.89M | ---- | ---- | ---- | ---- |
Research and development costs | -86.97%1.87M | ---- | ---- | ---- | ---- | 61.51%14.31M | ---- | ---- | ---- | ---- |
Depreciation and amortization | 12.39%5.28M | ---- | ---- | ---- | ---- | 18.51%4.7M | ---- | ---- | ---- | ---- |
-Depreciation | 12.39%5.28M | ---- | ---- | ---- | ---- | 18.51%4.7M | ---- | ---- | ---- | ---- |
Rent and land expenses | 3.09%47.7M | ---- | ---- | ---- | ---- | 0.49%46.27M | ---- | ---- | ---- | ---- |
Other operating expenses | 21.88%113.23M | ---- | ---- | ---- | ---- | 11.82%92.9M | ---- | ---- | ---- | ---- |
Operating profit | 206.87%266.52M | -2.43%82.24M | 146.22%61.93M | 267.50%41.99M | 336.30%80.37M | 52.41%86.85M | -0.53%84.29M | -30.03%25.15M | 229.04%11.43M | 37.99%-34.01M |
Net non-operating interest income (expenses) | 123.86%157K | 229.73%144K | 176.39%110K | 83.42%-31K | 69.44%-66K | 46.15%-658K | 58.11%-111K | 50.17%-144K | 44.01%-187K | 35.33%-216K |
Non-operating interest income | 94.85%454K | 194.74%168K | 175.00%165K | 8.47%64K | 0.00%57K | -1.27%233K | -1.72%57K | -1.64%60K | -1.67%59K | 0.00%57K |
Non-operating interest expense | -66.67%297K | -85.71%24K | -73.04%55K | -61.38%95K | -54.95%123K | -38.89%891K | -47.99%168K | -41.71%204K | -37.56%246K | -30.18%273K |
Net investment income | 2.76%51.77M | 9.09%120K | -37.81%658K | 9.01%121K | 3.61%50.88M | 186.98%50.38M | 113.11%110K | 80.55%1.06M | -69.42%111K | 181.46%49.1M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 0 | 145.30%18.29M | 0 | ||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | 93.87%-19K | 99.35%-2K | -17K | 0 | 0 | -111.20%-310K | -112.25%-310K | 0 | 0 | 0 |
Less:Other special charges | -93.87%19K | --2K | ---- | ---- | ---- | 111.20%310K | ---- | ---- | ---- | ---- |
Other non-operating income (expenses) | -19.11%3.53M | 60.15%852K | -83.80%117K | -53.73%954K | 53.34%1.61M | 87.86%4.36M | 157.51%532K | -61.18%722K | 215.29%2.06M | 42.78%1.05M |
Income before tax | 102.60%321.95M | -1.37%83.35M | 39.32%62.8M | 220.86%43.03M | 733.75%132.78M | 317.74%158.91M | 88.35%84.5M | 24.22%45.07M | 250.77%13.41M | 146.55%15.93M |
Income tax | -132.74%-5.97M | -449.14%-44.09M | -3.43%9.99M | 54.74%5.24M | 82.76%22.89M | -3.71%18.23M | -180.09%-8.03M | 448.57%10.35M | 96.46%3.39M | 136.44%12.52M |
Net income | 133.09%327.92M | 37.72%127.43M | 52.06%52.81M | 276.90%37.79M | 3,131.20%109.89M | 636.17%140.68M | 165.58%92.53M | 0.95%34.73M | 194.43%10.03M | 108.61%3.4M |
Net income continuous operations | 133.09%327.92M | 37.72%127.43M | 52.05%52.8M | 276.94%37.79M | 3,130.28%109.89M | 636.17%140.68M | 165.58%92.53M | 0.95%34.73M | 194.42%10.03M | 108.61%3.4M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 133.09%327.92M | 37.72%127.43M | 52.06%52.81M | 276.90%37.79M | 3,131.20%109.89M | 636.17%140.68M | 165.58%92.53M | 0.95%34.73M | 194.43%10.03M | 108.61%3.4M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 133.09%327.92M | 37.72%127.43M | 52.06%52.81M | 276.90%37.79M | 3,131.20%109.89M | 636.17%140.68M | 165.58%92.53M | 0.95%34.73M | 194.43%10.03M | 108.61%3.4M |
Gross dividend payment | ||||||||||
Basic earnings per share | 135.99%63.01 | 39.31%24.49 | 54.10%10.14 | 282.63%7.27 | 3,198.44%21.11 | 637.57%26.7 | 166.36%17.58 | 1.23%6.58 | 194.53%1.9 | 108.57%0.64 |
Diluted earnings per share | 135.99%63.01 | 39.27%24.484 | 54.10%10.14 | 282.78%7.2611 | 3,198.44%21.11 | 637.57%26.7 | 166.71%17.58 | 1.23%6.58 | 194.38%1.897 | 108.57%0.64 |
Dividend per share | 100.00%10 | 0.00%5 | 0 | 5 | 0 | 0.00%5 | 0.00%5 | 0 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |